Skip to content

Clinical Investigation Comparing Two Different Ultra-porous Coated Surfaces of Uncemented Cups

Modern Surfaces of the Uncemented Cup in Total Hip Arthroplasty: A Randomized, Clinical Investigation Comparing Two Different Ultra-porous Coated Surfaces of Uncemented Cups Using CT-based Micromotion Analysis and Clinical Evaluation

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05773261
Enrollment
70
Registered
2023-03-17
Start date
2022-09-09
Completion date
2039-09-09
Last updated
2023-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Hip

Keywords

Osteoarthritis, Total hip arthroplasty, Uncemented total hip arthroplasty

Brief summary

A randomised controlled study comparing two types of ultra-porous coated uncemented cups in total hip arthroplasty. Primary objective is to investigate if the clinical, radiological and patient-reported outcome of the new MobileLINK TabecuLINK cup combined with an X-LINKed insert is non-inferior to the clinical and radiological outcome of the Pinnacle Gription series 100 cup combined with the Marathon liner. Patients are evaluated up to 15 years postoperatively.

Detailed description

The purpose of this study is to evaluate the clinical outcome and long-term risk of development of osteolysis of a newly introduced cementless press-fit acetabular cup, consisting of a shell with a 3D surface structure and a highly cross-linked liner by precise measurement of early migration and wear. Migration describes the movement between the implant and the surrounding bone over time. Early migration of the implant, within 2 years after operation, has shown to be a strong predictor for increased risk for late failure. Thus, high precision migration studies can be used to evaluate the performance of new implants in small groups of patients with a relatively short observation time. Wear particles are one of the main causes of periprosthetic osteolysis. Although modern, more wear resistant materials, appears to have a greatly reduced risk of osteolysis, the desired complete elimination of osteolysis appears to be yet unachieved. It is most likely that the mechanism of periprosthetic osteolysis is multifactorial. In this study the investigators plan to include 70 patients that are planned for operation with an uncemented total hip arthroplasty. 35 patients will be randomized to receive the new implant and 35 patients will be included in the control group and receive a standard uncemented prosthesis. All patients will then be followed with CT scans and patient reported outcome measures 3-month, 1 year, 2 years, 5 years and 15 years after the operations. The CT scans will be used both for measurement of migration and wear and development of osteolysis around the implant.

Interventions

DEVICEMobilLINK TrabecuLINK cup

THA with MobilLINK TrabecuLINK cup and LCU stem

DEVICEPinnacle Gription cup

THA with Pinnacle Gription cup and Coral stem

Sponsors

University Hospital, Umeå
CollaboratorOTHER
Region Västerbotten
CollaboratorOTHER_GOV
Umeå University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Control: Pinnacle Gription series 100 cup with a Marathon liner combined med with a Corail femoral stem. Investigational device: MobilLINK TrabecuLINK cup with X-LINKed liner combined with a LCU femoral stem.

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients are foreseen for implantation of an uncemented acetabular press-fit cup and an uncemented stem * Age 30-70 years * Primary osteoarthritis of the hip * Body Mass Index between 18 and 35 kg/m2 * Willingness and ability to follow clinical investigation protocol

Exclusion criteria

* Grossly abnormal hip anatomy (hip dysplasia, Crowe Grade 2 or above, Perthes or other causes) * Osteoporosis * Paget's disease * Inflammatory arthritis * Secondary osteoarthritis * Presence of malignancy in the area of surgery * Treatment with bisphosphonates, cortisol or cytostatic drugs 6 months or less prior to surgery * Previous surgery in the affected hip * Inclusion of the contralateral hip in this clinical investigation * Not suited for the clinical investigation for other reason (surgeon's judgment) * Pregnant or breastfeeding women * Prison inmate

Design outcomes

Primary

MeasureTime frameDescription
Early migration of the cup2 years after operationMigration of the cup between 3 month and 2 years after implantation of the cup measured with Computed Tomography scan based Micromotion Analysis (CTMA) in mm.

Secondary

MeasureTime frameDescription
3D wear5 years after operationLiner wear measured as 3D penetration of the femoral head prosthesis into the liner between 1 year and 5 years after operation in mm
Long term migratio15 years after operationMigration of the cup measured in mm with CTMA
Long term wear15 years after operationLiner wear measured in mm with CTMA
Stem migration15 yearsDistal and 3D migration in mm of the stem between post- operative examination and 3 month, 3 month and 2 years, 3 month and 5 years and 3 month and 15 years.
Patient reported outcome with Forgotten Joint Score15 years after operationPatient-reported outcome measured by Forgotten Joint Score (FSJ). The scores will be summarized and transformed to a scale ranging from 0 to 100, where a high value indicate that the patient tends to be less aware of the affected joint when performing daily activities.
Patient reported outcome with Hip dysfunction and Osteoarthritis Outcome Score15 years after operationPatient-reported outcome measured by Hip dysfunction and Osteoarthritis Outcome Score (HOOS). Each of the 5 subscales will get a score of 0 to 100, with 0 indicating extreme symptoms and 100 indicating no symptoms. The subscales will be plotted as a HOOS profile, by connecting the mean scores for all 5 dimensions with a line.
Proximal wear5 years after operationLiner wear measured as proximal penetration of the femoral head prosthesis into the liner between 1 year and 5 years after operation in mm
Patient reported outcome with EuroQuol 5.15 years after operationPatient reported health related quality of life, measured by EuroQuol 5 dimensions (EQ-5D). For the calculation of the EQ-5D index the standard value set version 2.1 for Sweden is used. Index scores range from 0 ( 0 is the value of a health state equivalent to dead; negative values representing values as worse than dead) to 1 (the value of full health), with higher scores indicating higher health utility.
Reoperations15 years after operationIncidence and rate of revisions, re-operations and operation-related complications
Osteolysis15 years after operationIncidence and rate of patients showing osteolysis around the cup on CT scans and/or on x-rays
Precision of migration measurements with CTMA1 year after operationPrecision of migration measurement in mm with CTMA, by comparing double CT scans obtained on the same day at the 1 year follow-up.
Precision of wear mearurements with CTMA1 year after operationPrecision of wear measurement in mm with CTMA, by comparing double CT scans obtained on the same day at the 1 year follow-up.
Patient reported outcome with University of California, Los Angeles Activity Score15 years after operationPatient-reported outcome measured by University of California, Los Angeles Activity Score (UCLA). The patients physical activity level rank from 1 (low) to 10 (high).

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026